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Abstract
Typing of human enterovirus (EV) remains a major goal for diagnostic and epidemiological purposes. Whereas sequencing of the VP1 coding
region is the reference standard for EV typing, a method relying on sequencing of the VP2 coding region has been proposed as an alternative;
however, this has been validated only on cell culture supernatants. To avoid the selection of cultivable strains and to quicken the
identiﬁcation step, a new semi-nested PCR method targeting the VP2 region was developed by use of the CODEHOP strategy. After
validation of the method on reference and clinical strains, a total of 352 clinical specimens found to be positive for EV RNA (138 with the
GeneXpert EV kit and 214 with the Enterovirus R-gene kit) during a 3-year period (2010–2012) were analysed prospectively for VP2
genotyping. Overall, 204 (58%) specimens were typeable. A higher proportion of throat swab/stool specimens than of cerebrospinal ﬂuid
(CSF) specimens was found to be typeable (94 of 142 (66.2%) vs. 83 of 169 (49.1%), respectively, p <0.01 by the chi-square test). Moreover,
the median Ct value obtained was lower for typeable specimens than for untypeable specimens (32.20 vs. 33.01, p <0.05, and 25.96 vs. 31.74,
p <0.001, for the GeneXpert and R-gene tests, respectively, by the Mann–Whitney–Wilcoxon test). These results suggest that, in cases of
EV meningitis, a peripheral specimen (i.e. throat swab or stool) that is susceptible to exhibiting a higher viral load should be used in
preference to CSF for identifying the causative EV genotype by use of the VP2 typing method without cell culture isolation.
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Abstract
With the achievement of high coverage for routine immunization and supplementary immunization activities (SIAs), measles incidence in
mainland China reached its lowest level in 2010. The proportion of measles cases in the vaccination-targeted population decreased during
2007–2010 after the SIAs. More than 60% of measles cases were in adults or infants, especially in the coastal and eastern provinces during
2009 and 2010. A total 567 isolates of measles virus were obtained from clinical specimens from 27 of 31 provinces in mainland China during
2009 and 2010. Except for two vaccine-associated cases, one genotype D4 strain, two genotype D9 strains, and four genotype D11 strains,
the other 558 strains were genotype H1 cluster H1a. Genotype H1 has been the only endemic genotype detected in China since
surveillance began in 1993. Only genotype H1 was found in mainland China during 1993–2008, except for one detection of genotype H2.
More recently, multiple genotypes of imported measles were detected even with the background of endemic genetotype H1 viruses.
Analysis of the 450-nucleotide sequencing window of the measles virus N gene showed that the overall genetic diversity of the recent
geneotype H1 strains decreased between 2008 and 2010. The lower genetic diversity of H1 strains suggested that enhanced vaccination
may have reduced the co-circulating lineages of endemic genotype H1 strains in mainland China.
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Abstract
Few studies have examined the epidemiology of respiratory viral infections in large tertiary centres over more than one season in the era of
molecular diagnosis. Respiratory clinical specimens received between 1 January 2011 and 31 December 2012 were analysed. Respiratory
virus testing was performed using a large panel of real-time PCR or RT-PCR. Results were analysed according to sample type (upper versus
lower respiratory tract) and age group. In all, 2996 (2469 (82.4%) upper; 527 (17.6%) lower) specimens were analysed. Overall positivity
rate was 47.4% and 23.7% for upper and lower respiratory samples, respectively. The highest positivity rate was observed in patients under
18 years old (p <0.001); picornaviruses were the most frequent viruses detected over the year. Inﬂuenza virus, respiratory syncytial virus,
human metapneumovirus and coronaviruses showed a seasonal peak during the winter season, while picornaviruses and adenoviruses were
less frequently detected in these periods. Multiple viral infections were identiﬁed in 12% of positive cases and were signiﬁcantly more
frequent in children (p <0.001). In conclusion, we observed signiﬁcant differences in viral infection rates and virus types among age groups,
clinical sample types and seasons. Follow-up of viral detection over several seasons allows a better understanding of respiratory viral
epidemiology.
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